A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PAI / PA inhibitor

[Related PubMed/MEDLINE]
Total Number of Papers: 49
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PAI  (>> Co-occurring Abbreviation)
Long Form:   PA inhibitor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2008 Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues. PA, RCC, tPA, uPA
2008 uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer. NAF, PG, uPA
2007 Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum. CL, MMP, TIMP, tPA, uPA, uPAR
2005 Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. ECM, MMPs, NAC, NF-kappaB, PMA, ROS, TIMP, uPA, uPAR
2005 Plasminogen activator inhibitor-1 and diabetic nephropathy. ECM, PA
2004 Role of TGF-beta1 and JNK signaling in capillary tube patterning. TGF, TSP, uPA
2003 Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. HUVEC, MMPs, uPA
2003 Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. GnRHa, PA
1999 Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease. tPA
10  1999 The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis. PA
11  1998 Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. APC, i.v, PA
12  1997 Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: possible triggering of cardiovascular events after a major earthquake. BP, tPA, vWF
13  1997 Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice. BKV, CAT, LTR, PA, uPA
14  1997 [Changes of serum TNF-alpha level, t-PA activivty and PAI activity in patients with silent myocardial ischemia or silent cerebral ischemia]. SCI, SMI, TNF-alpha, tPA
15  1996 Plasminogen activator inhibitor type-2 in the lesional epidermis of lupus erythematosus. LE, PAI-2, tPA, uPA
16  1995 Regulation of rat granulosa cell plasminogen activator system: influence of interleukin-1 beta and ovarian follicular development. IL-1beta, PA
17  1994 In vitro production of plasminogen activator by human granulosa cells. PA
18  1994 Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin. PA, tPA
19  1993 Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study. PA, u-PA
20  1993 Partial characterization of the plasminogen activator produced by ovine embryos in vitro. EGD, PA
21  1993 Plasminogen activator inhibitors in endometrial adenocarcinoma. PA, PAI-2
22  1993 Plasminogen activators and their inhibitors in leukemic cell homogenates. AML, AMoL, APL, CML, PA, t-PA, uPA
23  1992 Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells. PA, uPAR
24  1992 Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium. NSAID, OA, PA, RA, tPA, uPA
25  1992 On the fibrinolytic system in aged rats, and its reactivity to endotoxin and cytokines. tPA, uPA
26  1992 [Study on fibrinolysis and platelet function]. EIA, PRP, tPA
27  1991 Activation of the plasminogen activator system in a keratinocyte cell line (HaCaT) by alkyl sulfates. HaCaT, tPA, uPA
28  1991 Comparison of the fibrinolytic response to desmopressin acetate (DDAVP) infusion versus venous occlusion in patients with coronary artery disease. tPA
29  1991 Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications. DIC, LPS, PAF, PMNs, TNF, tPA
30  1990 Changes in and partial identification of the plasminogen activator and plasminogen activator inhibitor systems during ovarian follicular maturation in the pig. FF, PA, t-PA
31  1990 Changes in tissue-type plasminogen activator-like and plasminogen activator inhibitor activities in granulosa and theca layers during ovarian follicle development in the domestic hen. GC, LWF, PA, pI, TT
32  1990 Developmental transition in plasticity properties of differentiating astrocytes: age-related biochemical profile of plasminogen activators in astroglial cultures. CNS, PA, u-PA
33  1990 Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion. tPA
34  1990 [Plasminogen activator in leukemic cell homogenate]. DIC, PA, t-PA, uPA
35  1989 A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. tPA
36  1989 A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method. BCEs, PAs
37  1989 Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. BAL, OA, PA
38  1989 Alterations in plasminogen activator and inhibitor activity during the differentiation of a human neuroblastoma cell line, SMS-KAN. PA, tPA, UK
39  1989 Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation. PA
40  1989 Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test. IF, PA
41  1989 Glucocorticoids stimulate plasminogen activator production by rat granulosa cells. PA, tPA
42  1989 Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells. PA, PAI-1, PAI-2, VSMC
43  1989 Plasminogen activator and plasminogen activator inhibitor in human preovulatory follicular fluid. PA, PAI-1
44  1989 The role of ovarian proteases and their inhibitors in ovulation. hCG, MW, PA, PMSG
45  1988 Altered fibrinolysis in DVT: influence of site of sampling. DVT, tPA
46  1988 Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour. PA, tPA, uPA
47  1988 Expression of plasminogen activator (PA) and a PA inhibitor in human granulosa cells from preovulatory follicles. PA, PAI-1, tPA
48  1988 Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. ---
49  1988 Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity. PA